tiprankstipranks
Trending News
More News >

OneSource Secures Brazilian GMP Certification for Flagship Facility

Story Highlights
OneSource Secures Brazilian GMP Certification for Flagship Facility

Don’t Miss TipRanks’ Half-Year Sale

OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) has provided an update.

OneSource Specialty Pharma Limited has received Good Manufacturing Practices (GMP) certification from ANVISA, the Brazilian Health Regulatory Agency, for its flagship Unit 2 facility. This certification, following a successful regulatory inspection, enhances the company’s operational capabilities and strengthens its position in the pharmaceutical market, potentially benefiting stakeholders by expanding its market reach in Brazil.

More about OneSource Specialty Pharma Limited

OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, operates in the pharmaceutical industry. The company specializes in providing contract development and manufacturing services, focusing on high-quality pharmaceutical production to meet global standards.

YTD Price Performance: -8.68%

Average Trading Volume: 27,864

Find detailed analytics on ONESOURCE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1